These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 39111078

  • 1. Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways.
    Wang X, Zhang L, Si H.
    Biomed Pharmacother; 2024 Sep; 178():117221. PubMed ID: 39111078
    [Abstract] [Full Text] [Related]

  • 2. Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice.
    Aromokeye R, Si H.
    Cancers (Basel); 2022 Jun 18; 14(12):. PubMed ID: 35740666
    [Abstract] [Full Text] [Related]

  • 3. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT, Lin J, Liu YE, Chen HF, Hsu KW, Lin SH, Peng KY, Lin KJ, Hsieh CC, Chen DR.
    Phytomedicine; 2021 Jan 18; 81():153437. PubMed ID: 33352494
    [Abstract] [Full Text] [Related]

  • 4. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S, Lee J, Jeon M, Lee JE, Nam SJ.
    Oncotarget; 2016 Jan 12; 7(2):1544-58. PubMed ID: 26637807
    [Abstract] [Full Text] [Related]

  • 5. Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.
    Fang T, Hu S, Song X, Wang J, Zuo R, Yun S, Jiang S, Guo D.
    Breast Cancer Res Treat; 2024 Sep 12; 207(2):435-451. PubMed ID: 38958784
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ.
    J Exp Clin Cancer Res; 2019 Mar 21; 38(1):134. PubMed ID: 30898152
    [Abstract] [Full Text] [Related]

  • 9. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H.
    Oncol Rep; 2017 Feb 21; 37(2):895-902. PubMed ID: 27959422
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R, Riveiro ME, Astorgues-Xerri L, Odore E, Rezai K, Erba E, Panini N, Rinaldi A, Kwee I, Beltrame L, Bekradda M, Cvitkovic E, Bertoni F, Frapolli R, D'Incalci M.
    Oncotarget; 2017 Jan 31; 8(5):7598-7613. PubMed ID: 27935867
    [Abstract] [Full Text] [Related]

  • 14. Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, Manore SG, Arrigo A, Jalboush SA, Wong GL, Yu Y, Wagner CJ, Chan M, Ruiz J, Thomas A, Strowd R, Lin J, Lo HW.
    Oncogene; 2020 Oct 31; 39(42):6589-6605. PubMed ID: 32929154
    [Abstract] [Full Text] [Related]

  • 15. Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
    Shao M, Lou D, Yang J, Lin M, Deng X, Fan Q.
    Phytomedicine; 2020 Dec 31; 79():153341. PubMed ID: 32992086
    [Abstract] [Full Text] [Related]

  • 16. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J, Chen X, Fu S, Zhang R, Pan L, Cao Y, Wu X, Xiao H, Lin HJ, Lo HW, Zhang Y, Lin J.
    Breast Cancer Res Treat; 2019 Jun 31; 175(3):553-566. PubMed ID: 30852762
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.